MST Continus 200 mg prolonged-release tablets – Summary of Product Characteristics (SmPC) for healthcare professionals
Medicine status: Controlled drug (Schedule 2) No longer supplied Details
- Medicine strength:
- 200 mg
- Other strengths and forms:
-
- MST Continus 5 mg prolonged-release tablets
- MST Continus 10 mg prolonged release tablets
- MST Continus 15 mg prolonged-release tablets
- MST Continus 30 mg prolonged-release tablets
- MST Continus 60 mg prolonged-release tablets
- MST Continus 100 mg prolonged-release tablets
- MST Continus suspension 20 mg
- MST Continus suspension 30 mg
- MST Continus suspension 60 mg
- MST Continus suspension 100 mg
- MST Continus suspension 200 mg
- Contains active substance:
- ATC code:
Sources: Original (products.mhra.gov.uk)
Facts about MST Continus 200 mg prolonged-release tablets
| Controlled drug? |
Yes, Schedule 2 of the Misuse of Drugs Regulations
|
|---|---|
| Active substance? | Morphine |
| Strength? | 200 mg |
| Pharmaceutical form? | Modified-release tablet |
| How is it taken? | Oral |
| Is it available?? | No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies) |
| Drug group (ATC)? | |
| Codes? | BNF 04070200 |
Sources: the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.
